Documentos de Silva-Sieger F.A. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área temáticas: "Salud y seguridad personal"

Subtipo de publicación

Publisher

International Journal of Cardiology(1)

International Journal of Stroke(1)

Nutrition, Metabolism and Cardiovascular Diseases(1)

Área temáticas

Farmacología y terapéutica(2)

Enfermedades(1)

Fisiología humana(1)

Área de conocimiento

Medicina interna(2)

Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar(4)

ODS 17: Alianzas para lograr los objetivos(3)

ODS 2: Hambre cero(3)

ODS 10: Reducción de las desigualdades(1)

ODS 12: Producción y consumo responsables(1)

Año de Publicación

Origen

Palabras Claves

Acute ischaemic stroke(1)

Endothelial function(1)

Hypertension(1)

A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

Abstract: Background: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a

Palabras claves:

Lahera V., Márquez G.A., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P., Rueda-Clausen C.F., Silva-Sieger F.A.

Epidemic of overweight and obesity in Latin America and the Caribbean

Palabras claves:

PATRICIO LOPEZ -JARAMILLO, Rueda-Clausen C.F., Silva-Sieger F.A.

Olive, soybean and palm oils intake have a similar acute detrimental effect over the endothelial function in healthy young subjects

Abstract: Background and aim: Currently, more than 30% of the caloric intake in the Colombian population comes

Palabras claves:

Endothelial function, Olive, palm, soybean, vegetable oils, Young volunteers

CURE‐CURE C., Gomez E., Gutierrez R., Lindarte M.A., PATRICIO LOPEZ -JARAMILLO, Rueda-Clausen C.F., Silva-Sieger F.A., Villa-Roel C.

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment

Abstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminog

Palabras claves:

Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysis

Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.